The effects of awareness, treatment and control of hypertension on cardiovascular and all-cause mortality in a community-based population

Journal of Human Hypertension

Volumn 23, Issue 12, 2009, Pages 808-816

  Barengo, N C ^a,b   Kastarinen, M ^c   Antikainen, R ^d,e   Nissinen, A ^f   Tuomilehto, J ^a,g  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d Oulu City Hospital   (Finland)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL;

ADULT; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATION; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; SMOKING;

ADULT; ANTIHYPERTENSIVE AGENTS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS;

EID: 70749136849     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.30     Document Type: Article

References (35)

1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA et al. Blood pressure, stroke and coronary heart disease. Part 2: Short term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-839.
2. Boudik F, Reissigova J, Hrach K, Tomeckova M, Bultas J, Anger Z et al. Primary prevention of coronary artery disease among middle aged men in Prague: Twenty-year follow-up results. Atherosclerosis 2006; 184: 86-93.
3. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. J Hypertens 2006; 24: 423-430.
4. Gueyffier F, Boutitie F, Boissel JP, Pocock S, Coope J, Cutler J et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med 1997; 126: 761-767.
5. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277: 739-745.
6. Almgren T, Persson B, Wilhelmsen L, Rosengren A, Andersson OK. Stroke and coronary heart disease in treated hypertension - a prospective cohort study over three decades. J Intern Med 2005; 257: 496-502.
7. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K et al. The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J 1986; 7: 279-288.
8. Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: Follow up study after two decades. BMJ 1998; 317: 167-171.
9. Clausen J, Jensen G. Blood pressure and mortality: An epidemiological survey with 10 years follow-up. J Hum Hypertens 1992; 6: 53-59.
10. Gudmundsson LS, Johannsson M, Thorgeirsson G, Sigfusson N, Sigvaldason H, Witteman JC. Hypertension control as predictor of mortality in treated men and women, followed for up to 30 years. Cardiovasc Drugs Ther 2005; 19: 227-235.
11. Casiglia E, Mazza A, Tikhonoff V, Pessina AC. Population-based studies improve outcome in hypertensive patients. Am J Hypertens 2002; 15: 605-608.
12. Bulpitt CJ, Palmer AJ, Fletcher AE, Beevers DG, Coles EC, Ledingham JG et al. Optimal blood pressure control in treated hypertensive patients. Report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation 1994; 90: 225-233.
13. Trafford JA, Horn CR, O'Neal H, McGonigle R, Halford-Maw L, Evans R. Five year follow-up of effects of treatment of mild and moderate hypertension. Br Med J (Clin Res Ed) 1981; 282: 1111-1113.
14. Benetos A, Thomas F, Bean K, Gautier S, Smulyan H, Guize L. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med 2002; 162: 577-581.
15. Harms LM, Schellevis FG, van Eijk JT, Donker AJ, Bouter LM. Cardiovascular morbidity and mortality among hypertensive patients in general practice: The evaluation of long-term systematic management. J Clin Epidemiol 1997; 50: 779-786.
16. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol 2000; 29: 49-56.
17. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): A major international collaboration. J Clin Epidemiol 1988; 41: 105 14.
18. Tuomilehto J, Vartiainen E, Sarti C, Nissinen A, Kastarinen M. Trends in hypertension, cardiovascular risk and stroke mortality in Finland. In: Bulpitt C (ed). Epidemiology of Hypertension, Hypertension Handbook Elsevier Science B.V Amsterdam 2000, pp 633-644.
19. Gudmundsson LS, Johannsson M, Thorgeirsson G, Sigfusson N, Sigvaldason H,Witteman JC. Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study: The Reykjavik Study. J Hum Hypertens 2004; 18: 615-622.
20. Kastarinen MJ, Antikainen RL, Laatikainen TK, Salomaa VV, Tuomilehto JO, Nissinen AM et al. Trends in hypertension care in eastern and south-western Finland during 1982-2002. J Hypertens 2006; 24 829-836.
21. Kastarinen M, Laatikainen T, Salomaa V, Jousilahti P, Antikainen R, Tuomilehto J et al. Trends in lifestyle factors affecting blood pressure in hypertensive and normotensive Finns during 1982-2002. J Hypertens 2007; 25: 299-305.
22. Kastarinen M, Tuomilehto J, Vartiainen E, Jousilahti P, Sundvall J, Puska P et al. Trends in lipid levels and hypercholesterolemia in hypertensive and normotensive Finnish adults from 1982 to 1997. J Intern Med 2000; 247: 53-62.
23. Kastarinen MJ, Nissinen AM, Vartiainen EA, Jousilahti PJ, Korhonen HJ, Puska PM et al. Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997. J Hypertens 2000; 18: 255-262.
24. Antikainen RL, Moltchanov VA, Chukwuma Sr C, Kuulasmaa KA, Marques-Vidal PM, Sans S et al. WHO MONICA Project. Trends in the prevalence, awareness, treatment and control of hypertension: The WHO MONICA Project. Eur J Cardiovasc Prev Rehabil 2006; 13: 13-29.
25. Kastarinen MJ, Salomaa VV, Vartiainen EA, Jousilahti PJ, Tuomilehto JO, Puska PM et al. Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertens 1998; 16 1379-1387.
26. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension 1995; 26: 60-69.
27. Ribacke M, Tibblin G, Rosengren A, Eriksson H. Is hypertension changing? Blood pressure development in cohorts of 50-year-old men between 1963 and 1993. Blood Press 1996; 5: 134-138.
28. Kastarinen MJ, Puska PM, Korhonen MH, Mustonen JN, Salomaa VV, Sundvall JE et al. Non-pharmacological treatment of hypertension in primary health care: A 2-year open randomized controlled trial of lifestyle intervention against hypertension in eastern Finland. J Hypertens 2002; 20: 2505-2512.
29. Yosefy C, Dicker D, Viskoper JR, Tulchinsky TH, Ginsberg GM, Leibovitz E et al. The Ashkelon Hypertension Detection and Control Program (AHDC Program): A community approach to reducing cardiovascular mortality. Prev Med 2003; 37: 571-576.
30. Guidelines Subcommittee. 2003 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
31. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003; 289: 2560-2572.
32. Kiiskinen U, Vartiainen E, Puska P, Aromaa A. Long-term cost and life-expectancy consequences of hypertension. J Hypertens 1998; 16: 1103-1101.
33. Nilsson PM, Engström G, Hedblad B. Long-term predictors of increased mortality risk in screened men with new hypertension; the Malmo preventive project. J Hypertens 2008; 26: 2288-2294.
34. Staessen JA, Thijs L, Fagard R, Celis H, Birehäger WH, Bulpitt CJ et al. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens 2004; 22: 1-11.
35. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: A population based study. Am J Hypertens 2006; 19: 243-250.